TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
83.20
-1.80 (-2.12%)
At close: Dec 5, 2025

TTY Biopharm Company Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
1,7901,4501,1291,094831.89924.18
Upgrade
Depreciation & Amortization
200.07194.26193.1180.69162.79153.86
Upgrade
Other Amortization
88.097.85.594.493.14
Upgrade
Loss (Gain) From Sale of Assets
1.720.951.933.280.740.32
Upgrade
Asset Writedown & Restructuring Costs
26.986.8116.180.734.154.58
Upgrade
Loss (Gain) From Sale of Investments
-0.95-8.79-0.21-0.16
Upgrade
Loss (Gain) on Equity Investments
-399.01-400.05-131.34-116.38-135.18-162.87
Upgrade
Provision & Write-off of Bad Debts
0.31.36-1.933.5613.58-0.1
Upgrade
Other Operating Activities
360.5202.01122.02110.34110.24-15.66
Upgrade
Change in Accounts Receivable
-343.3835.07-116.16-95.4-114.32-36.42
Upgrade
Change in Inventory
21.11-161.27-56.75-83.95155.12-251.8
Upgrade
Change in Accounts Payable
57.42-10.2111.9596.01-23.07-26.35
Upgrade
Change in Unearned Revenue
4.1420.11-18.89-6.6423.48-0.39
Upgrade
Change in Other Net Operating Assets
56.662.63-179.8943.55222.24-65.98
Upgrade
Operating Cash Flow
1,7841,3491,0851,2361,256526.35
Upgrade
Operating Cash Flow Growth
58.98%24.33%-12.17%-1.64%138.69%-56.49%
Upgrade
Capital Expenditures
-135.64-125.16-78.35-91.52-60.32-168.11
Upgrade
Sale of Property, Plant & Equipment
2.543.937.019.390.030.01
Upgrade
Cash Acquisitions
--242.87----
Upgrade
Sale (Purchase) of Intangibles
-38.41-9.14-21.23-43.98-13.84-13.75
Upgrade
Investment in Securities
-73.92128.18168.5534.68-14.1308.82
Upgrade
Other Investing Activities
-45.051.49-78.62-41.7-80.5620.26
Upgrade
Investing Cash Flow
-289-243.56-2.63-133.14-168.78147.24
Upgrade
Short-Term Debt Issued
-8,05010,28010,8905,4005,400
Upgrade
Long-Term Debt Issued
-500400430-720
Upgrade
Total Debt Issued
6,5008,55010,68011,3205,4006,120
Upgrade
Short-Term Debt Repaid
--8,300-10,200-11,231-5,404-5,246
Upgrade
Long-Term Debt Repaid
--409.77-434.17-421.55-16.54-663.65
Upgrade
Total Debt Repaid
-6,809-8,710-10,634-11,653-5,421-5,910
Upgrade
Net Debt Issued (Repaid)
-308.82-159.7745.83-332.62-20.54210.35
Upgrade
Common Dividends Paid
-1,058-870.28-845.41-745.95-994.6-994.6
Upgrade
Other Financing Activities
-15.59-21.19-16.75-24.83-28.99-22.36
Upgrade
Financing Cash Flow
-1,383-1,051-816.33-1,103-1,044-806.61
Upgrade
Foreign Exchange Rate Adjustments
-56.6197.02-2.66135.85-44.91-65.41
Upgrade
Net Cash Flow
55.57151.6263.7135.07-1.48-198.43
Upgrade
Free Cash Flow
1,6481,2241,0071,1441,196358.25
Upgrade
Free Cash Flow Growth
59.92%21.57%-12.00%-4.33%233.86%-68.58%
Upgrade
Free Cash Flow Margin
25.35%20.77%18.29%22.61%26.37%8.49%
Upgrade
Free Cash Flow Per Share
6.624.914.044.594.801.44
Upgrade
Cash Interest Paid
38.8938.4634.9923.2218.6719.6
Upgrade
Cash Income Tax Paid
379.08297.06283.71277.92220.22311.47
Upgrade
Levered Free Cash Flow
769.68891.34737.63806.96980.02107.23
Upgrade
Unlevered Free Cash Flow
793.75915.25759.62821.24991.87119.36
Upgrade
Change in Working Capital
-204.05-113.67-359.75-46.44263.45-380.95
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.